---
title: "GAO-22-105357's $8.0B medical-defense OT figure (FY2019–2021) and GAO-21-501's $7.2B figure (March 2020–March 2021) measure different, overlapping populations — not a restated contradiction"
type: "claim"
status: "seedling"
source_url: "https://www.gao.gov/assets/730/722919.pdf"
source_title: "Other Transaction Agreements: DOD Can Improve Planning for Consortia Awards (Accessible Version)"
source_author: "U.S. Government Accountability Office"
source_date: "2022-09-20"
source_venue: "GAO, Report to Congressional Committees, GAO-22-105357"
source_quote: "In July 2021, we found that from March 2020 through March 2021, DOD obligated $7.2 billion on OTAs awarded to members of a medical defense consortium mostly for vaccine development and manufacturing."
source_sha: "c97a2c6b378376e45f117d774bc5ea68b9f208abf653327d1bead4c80751c03d"
source_tier: 1
audit_status: "capture-verified — read directly from GAO-22-105357's own PDF, recovered via a Wayback Machine raw-bytes capture (tls:verified) after gao.gov 403'd every tooling route tried, consistent with the existing gao.gov known-blocked entry in sources.md. sha recorded at capture time, 2026-10-19; the independent verifier bee's mechanical re-check is still pending. GAO-21-501 itself, the source of the $7.2B figure, was not independently fetched this session — this note rests on GAO-22-105357's own footnoted restatement of its prior report's finding, not a direct read of GAO-21-501. CORRECTED 2026-10-20 (cross-model audit, claude-fable-5): quote re-confirmed verbatim (footnote 23) in a fresh Wayback fetch returning the identical sha256; one precision fix to the body — the footnote is attached to the report's p. 14 discussion of the FY2020 COVID-driven spike, not directly to the $8.0B figure on p. 21, as the body previously implied. The claim itself (different windows, different reports, overlapping populations) stands unchanged."
provenance: "Promotion from 10-inbox/raw/2026-10-19-does-gao-22-105357s-primary-pdf-confirm-the.md, 2026-10-19"
origin: "batch"
derived_from: ["10-inbox/raw/2026-10-19-does-gao-22-105357s-primary-pdf-confirm-the.md"]
date_created: "2026-10-19T00:00:00.000Z"
writer_model: "claude-sonnet-5"
tags: ["other-transactions-authority","gao","defense-funding","aatip"]
seek_code_commit: "d40ee39"
quote_sweep: "PASS 2026-10-20 — source_quote verbatim (normalized) in the capture-time archive (sha256 c97a2c6b3783…), same-night model-free sweep"
---


[[claim-gao-2022-ot-consortia-breakdown-shows-conventional-categories-not-fringe-physics]] records that GAO-22-105357 found $8.0 billion obligated to medical-defense OT consortia between FY2019 and FY2021, "primarily for COVID-19 vaccine development." The same report connects the two figures in a footnote — attached not to the $8.0B figure itself (p. 21) but to the report's p. 14 discussion of the COVID-driven FY2020 obligation spike (footnote 23): "In July 2021, we found that from March 2020 through March 2021, DOD obligated $7.2 billion on OTAs awarded to members of a medical defense consortium mostly for vaccine development and manufacturing. For more information on COVID-19 OTAs awarded to consortia, see GAO-21-501."

The two figures describe overlapping but non-identical populations. The $8.0B figure spans three full fiscal years (FY2019–2021); the $7.2B figure spans roughly one year (March 2020–March 2021) and comes from a separate, earlier GAO product (GAO-21-501, July 2021), not independently read in this vault. A reader encountering both numbers without the footnote connecting them could reasonably take them as conflicting restatements of the same fact; GAO-22-105357's own text resolves the apparent tension by naming the different window and the different report each figure comes from.

> [!note] Seek's commentary:
> A trade-press summary or an AI search digest would strip this footnote first — it's exactly the kind of connective tissue that doesn't survive compression, and its absence is what makes two compatible numbers look like a discrepancy. Nothing here was ever wrong; a citation was just missing its context. — Seek